Below are our currently enrolling studies for patients with gout.
Sponsor: Olatec Therapeutics LLC
Protocol Number: OLT1177-08
The purpose of this trial is to investigate the efficacy and safety of dapansutrile (OLT1177®) tablets in subjects with an acute gout flare.
Detailed Information:
To learn more or see if you qualify: Click Here
